NeuroLutions

Overview
News
Brain-computer Interfaces?
Product stageSegments
Early
?
Non-invasive wearables
?

Neurolutions is a medical technology company focused on developing innovative solutions for neurorehabilitation, specifically targeting patients suffering from neurological conditions such as stroke. Their flagship product, the IpsiHand System, is a breakthrough therapeutic device that utilizes non-invasive brain-computer interface (BCI) technology to aid in the rehabilitation of chronic stroke patients with impaired upper extremity function.

The IpsiHand System works by capturing brain signals through electroencephalography (EEG) and translating them into commands that control a virtual reality environment. This allows stroke survivors to perform therapeutic exercises by simply thinking about the desired movements, bypassing the damaged motor pathways in the brain. The system aims to facilitate neuroplasticity and promote functional recovery by reinforcing the neural connections associated with movement.

Neurolutions has conducted extensive clinical trials and research to validate the efficacy of the IpsiHand System, which received FDA clearance in the US in 2022. The device is designed for use in both clinical settings and at-home rehabilitation programs, providing stroke survivors with a convenient and accessible means of continuing their therapy.

Key customers and partnerships

In November 2023, Neurolutions formed a strategic partnership with Kandu Health, a tech-enabled healthcare services company specializing in stroke recovery and post-acute care. Through this collaboration, Kandu Health's expert clinicians will provide consultations and assessments to identify stroke survivors who could benefit from the IpsiHand System. This partnership aims to streamline access to Neurolutions' innovative technology while ensuring patients receive comprehensive clinical support throughout their recovery journey.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
St Louis MO USA
Founded year:
2007
Employees:
1-10
IPO status:
Private
Total funding:
USD 1.3 mn
Last Funding:
-
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.